secwatch.observer — SEC 8-K summary
======================================

Issuer:     IO Biotech, Inc. (IOBTQ)
CIK:        0001865494
Form:       8-K
Filed at:   2024-01-08T23:59:59+00:00
Accession:  0001193125-24-003947
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

IO Biotech presents at J.P. Morgan conference; confirms cash runway into Q4 2025
--------------------------------------------------------------------------------

- Company presenting at 42nd Annual J.P. Morgan Healthcare Conference on January 8, 2024.
- Updated corporate presentation posted; confirms projected cash runway through Q4 2025.
- No new clinical data or financial results disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1865494/000119312524003947/0001193125-24-003947-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1865494/000119312524003947/d805340d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-003947

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer